{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:08:46Z","timestamp":1783480126124,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA035217"],"award-info":[{"award-number":["DA035217"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA047269"],"award-info":[{"award-number":["DA047269"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH121454"],"award-info":[{"award-number":["MH121454"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.neuropharm.2021.108830","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T12:02:24Z","timestamp":1633608144000},"page":"108830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Ibudilast attenuates cocaine self-administration and prime- and cue-induced reinstatement of cocaine seeking in rats"],"prefix":"10.1016","volume":"201","author":[{"given":"Lianwei","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5567-2520","authenticated-orcid":false,"given":"Vladislav","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8390-0818","authenticated-orcid":false,"given":"Thomas J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-1504","authenticated-orcid":false,"given":"Qing-song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108830_bib1","doi-asserted-by":"crossref","first-page":"9092","DOI":"10.1523\/JNEUROSCI.1001-08.2008","article-title":"Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area","volume":"28","author":"Argilli","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0091-3057(96)00445-5","article-title":"A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement","volume":"57","author":"Arnold","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2021.108830_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1523\/JNEUROSCI.20-01-00089.2000","article-title":"Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase","volume":"20","author":"Banke","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-420118-7.00001-9","article-title":"Glial modulators as potential treatments of psychostimulant abuse","volume":"69","author":"Beardsley","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108830_bib5","doi-asserted-by":"crossref","first-page":"9.39.1","DOI":"10.1002\/0471142301.ns0939s61","article-title":"Prime-, stress-, and cue-induced reinstatement of extinguished drug-reinforced responding in rats: cocaine as the prototypical drug of abuse","volume":"61","author":"Beardsley","year":"2012","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2010.04.010","article-title":"The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse","volume":"637","author":"Beardsley","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108830_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/adb.12106","article-title":"Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence","volume":"20","author":"Bell","year":"2015","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2021.108830_bib8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nn1682","article-title":"Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression","volume":"9","author":"Bellone","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib9","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1126\/science.1237059","article-title":"Cocaine disinhibits dopamine neurons by potentiation of GABA transmission in the ventral tegmental area","volume":"341","author":"Bocklisch","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108830_bib10","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.1523\/JNEUROSCI.1312-04.2004","article-title":"Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats","volume":"24","author":"Borgland","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015870","article-title":"Drug-driven AMPA receptor redistribution mimicked by selective dopamine neuron stimulation","volume":"5","author":"Brown","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2021.108830_bib12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1523\/JNEUROSCI.15-02-01249.1995","article-title":"Presynaptic enhancement of inhibitory synaptic transmission by protein kinases A and C in the rat hippocampus in vitro","volume":"15","author":"Capogna","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1523\/JNEUROSCI.14-01-00310.1994","article-title":"Increased transmitter release at excitatory synapses produced by direct activation of adenylate cyclase in rat hippocampal slices","volume":"14","author":"Chavez-Noriega","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib14","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1523\/JNEUROSCI.17-22-08687.1997","article-title":"The mechanism of cAMP-mediated enhancement at a cerebellar synapse","volume":"17","author":"Chen","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11481-011-9337-9","article-title":"Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats","volume":"7","author":"Chen","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108830_bib16","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1113\/jphysiol.2011.210807","article-title":"Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area","volume":"589","author":"Chieng","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108830_bib17","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1074\/jbc.R200029200","article-title":"Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic amp signaling","volume":"278","author":"Conti","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2021.108830_bib18","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/adb.12261","article-title":"The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers","volume":"21","author":"Cooper","year":"2016","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2021.108830_bib20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/JCP.0000000000000511","article-title":"Safety of intravenous methamphetamine administration during ibudilast treatment","volume":"36","author":"DeYoung","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2021.108830_bib21","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/540S7a","article-title":"Therapies: progressive steps","volume":"540","author":"Dolgin","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108830_bib22","doi-asserted-by":"crossref","first-page":"10867","DOI":"10.1523\/JNEUROSCI.1821-17.2017","article-title":"Circuit and synaptic plasticity mechanisms of drug relapse","volume":"37","author":"Dong","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2014.07.050","article-title":"Interactions of innate and adaptive immunity in brain development and function","volume":"1617","author":"Filiano","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108830_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41398-021-01478-5","article-title":"Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial","volume":"11","author":"Grodin","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2021.108830_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","article-title":"Controversies in translational research: drug self-administration","volume":"199","author":"Haney","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2021.108830_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.tips.2017.12.004","article-title":"Opioid and psychostimulant plasticity: targeting overlap in nucleus accumbens glutamate signaling","volume":"39","author":"Hearing","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.134.3483.943","article-title":"Progressive ratio as a measure of reward strength","volume":"134","author":"Hodos","year":"1961","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108830_bib28","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1111\/ejn.14143","article-title":"Neuroimmune mechanisms of psychostimulant and opioid use disorders","volume":"50","author":"Hofford","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib29","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.lfs.2005.10.026","article-title":"Preferential inhibition of human phosphodiesterase 4 by ibudilast","volume":"78","author":"Huang","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0092-8674(00)81509-3","article-title":"BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex","volume":"98","author":"Huang","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2021.108830_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1113\/jphysiol.1992.sp019136","article-title":"Two types of neurone in the rat ventral tegmental area and their synaptic inputs","volume":"450","author":"Johnson","year":"1992","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108830_bib33","doi-asserted-by":"crossref","first-page":"9780","DOI":"10.1523\/JNEUROSCI.19-22-09780.1999","article-title":"Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area","volume":"19","author":"Jones","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib34","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1523\/JNEUROSCI.0999-04.2004","article-title":"Presynaptic mechanism underlying cAMP-dependent synaptic potentiation","volume":"24","author":"Kaneko","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/adb.12086","article-title":"A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats","volume":"19","author":"Keck","year":"2014","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2021.108830_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1527-3466.2001.tb00066.x","article-title":"Ibudilast: a non-selective PDE inhibitor with multiple actions on blood cells and the vascular wall","volume":"19","author":"Kishi","year":"2001","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.neuropharm.2021.108830_bib38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature11527","article-title":"Input-specific control of reward and aversion in the ventral tegmental area","volume":"491","author":"Lammel","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108830_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107776","article-title":"Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder","volume":"206","author":"Li","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2021.108830_bib40","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/ALN.0b013e3181bdfa11","article-title":"Modulation of morphine-induced antinociception in acute and chronic opioid treatment by ibudilast","volume":"111","author":"Lilius","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2021.108830_bib41","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature04050","article-title":"Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons","volume":"437","author":"Liu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108830_bib42","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1523\/JNEUROSCI.3186-15.2016","article-title":"Epac signaling is required for cocaine-induced change in AMPA receptor subunit composition in the ventral tegmental area","volume":"36","author":"Liu","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib43","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s00213-017-4631-8","article-title":"The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL\/6J mice","volume":"234","author":"Liu","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2021.108830_bib44","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/npp.2017.96","article-title":"PDE4 inhibition restores the balance between excitation and inhibition in VTA dopamine neurons disrupted by repeated in vivo cocaine exposure","volume":"42","author":"Liu","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108830_bib45","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1126\/science.1142365","article-title":"Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area","volume":"317","author":"Mameli","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108830_bib46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnint.2013.00093","article-title":"Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of lister hooded rats","volume":"7","author":"Melis","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00213-008-1309-2","article-title":"Electrophysiological properties of dopamine neurons in the ventral tegmental area of Sardinian alcohol-preferring rats","volume":"201","author":"Melis","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2021.108830_bib48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","article-title":"Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures","volume":"14","author":"Mello","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108830_bib49","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/npp.2017.70","article-title":"Effects of ibudilast on the subjective, reinforcing, and analgesic effects of oxycodone in recently detoxified adults with opioid dependence","volume":"42","author":"Metz","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108830_bib50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrn.2016.165","article-title":"Ventral tegmental area: cellular heterogeneity, connectivity and behaviour","volume":"18","author":"Morales","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.650785","article-title":"Neuroimmune mechanisms as novel treatment targets for substance use disorders and associated comorbidities","volume":"15","author":"Namba","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib74","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11515-016-1424-0","article-title":"Phosphodiesterase 4 inhibitors and drugs of abuse: current knowledge and therapeutic opportunities","volume":"11","author":"Olsen","year":"2016","journal-title":"Frontiers in Biology"},{"key":"10.1016\/j.neuropharm.2021.108830_bib52","doi-asserted-by":"crossref","first-page":"14018","DOI":"10.1523\/JNEUROSCI.4035-08.2008","article-title":"D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling","volume":"28","author":"Pan","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib53","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1523\/JNEUROSCI.4033-07.2008","article-title":"Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons","volume":"28","author":"Pan","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104500","article-title":"Electrophysiological monitoring of inhibition in mammalian species, from rodents to humans","volume":"130","author":"Peyrache","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2021.108830_bib55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuropharm.2016.06.024","article-title":"Ibudilast attenuates expression of behavioral sensitization to cocaine in male and female rats","volume":"109","author":"Poland","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108830_bib56","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/ejn.13879","article-title":"Synaptic function and plasticity in identified inhibitory inputs onto vta dopamine neurons","volume":"47","author":"Polter","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108830_bib57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.npp.1300315","article-title":"Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats","volume":"29","author":"Raghavendra","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108830_bib58","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/npp.2017.10","article-title":"Development of the neuroimmune modulator ibudilast for the treatment of alcoholism: a randomized, placebo-controlled, human laboratory trial","volume":"42","author":"Ray","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108830_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2021.108830_bib60","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5604\/01.3001.0010.3798","article-title":"Ibudilast: a nonselective phosphodiesterase inhibitor in brain disorders","volume":"71","author":"Schwenkgrub","year":"2017","journal-title":"Postepy Hig. Med. Dosw."},{"key":"10.1016\/j.neuropharm.2021.108830_bib61","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2013.01.016","article-title":"Glial cell modulators attenuate methamphetamine self-administration in the rat","volume":"701","author":"Snider","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108830_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2012.01.013","article-title":"The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice","volume":"679","author":"Snider","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108830_bib64","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/jpet.117.241141","article-title":"Effects of acute and chronic treatments with dopamine D2 and D3 receptor ligands on cocaine versus food choice in rats","volume":"362","author":"Thomsen","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108830_bib65","first-page":"e53825","article-title":"Preparation of acute brain slices using an optimized N-Methyl-D-glucamine protective recovery method","volume":"132","author":"Ting","year":"2018","journal-title":"J Vis. Exp."},{"key":"10.1016\/j.neuropharm.2021.108830_bib66","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/35079077","article-title":"Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons","volume":"411","author":"Ungless","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108830_bib67","first-page":"1","article-title":"T-type calcium channels contribute to burst firing in a subpopulation of medial habenula neurons","volume":"7(4) 0201-20.2020","author":"Vickstrom","year":"2020","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2021.108830_bib68","article-title":"Application of optogenetics and in vivo imaging approaches for elucidating the neurobiology of addiction","author":"Vickstrom","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2021.108830_bib69","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/301603a0","article-title":"Facilitated induction of hippocampal long-lasting potentiation during blockade of inhibition","volume":"301","author":"Wigstrom","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108830_bib70","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00213-016-4470-z","article-title":"Reinforcing properties of an intermittent, low dose of ketamine in rats: effects of sex and cycle","volume":"234","author":"Wright","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2021.108830_bib71","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/npp.2016.155","article-title":"CTDP-32476: a promising agonist therapy for treatment of cocaine addiction","volume":"42","author":"Xi","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108830_bib72","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1301552","article-title":"Cannabinoid CB1 receptor antagonists attenuate cocaine\u2019s rewarding effects: experiments with self-administration and brain-stimulation reward in rats","volume":"33","author":"Xi","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108830_bib73","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nn.2808","article-title":"Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety","volume":"14","author":"Zweifel","year":"2011","journal-title":"Nat. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821003853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821003853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:12:26Z","timestamp":1758438746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821003853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":70,"alternative-id":["S0028390821003853"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108830","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ibudilast attenuates cocaine self-administration and prime- and cue-induced reinstatement of cocaine seeking in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108830"}}